Open access
Open access
Powered by Google Translator Translator

Daily Archives: March 16, 2018

Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops

16 Mar, 2018 | 03:37h | UTC

#ACC18 – Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops – New England Journal of Medicine (free for a limited period)

Commentaries: Barbershop-Based Intervention Leads to Blood Pressure Reductions in African-American Men – American College of Cardiology (free) AND Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control – TCTMD (free)

“Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in larger blood-pressure reduction when coupled with medication management in barbershops by specialty-trained pharmacists”.

 


Research: Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity

16 Mar, 2018 | 03:38h | UTC

#ACC18 – Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Beta Blocker Shows Mixed Results in Protecting Against Chemo-Induced Heart Damage – American College of Cardiology (free) AND Carvedilol Effect in Preventing Chemotherapy Induced CardiotoxicitY – CECCY – American College of Cardiology (free)

Related study from #ACC18: Heart Drugs Prevented Cardiotoxicity in Breast Cancer Treated With Anthracycline and Trastuzumab – American College of Cardiology (free)

“According to the CECCY trial, carvedilol had no effect on left ventricular function in breast cancer patients treated w/ doxorubicin, but did result in a reduction in troponin I levels & diastolic dysfunction”. (via @ACCinTouch see Tweet)

 


Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care

16 Mar, 2018 | 03:36h | UTC

#ACC18 – Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care – American College of Cardiology (free) AND Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure – TCTMD (free)

 


Viewpoint: Big Data and Machine Learning in Health Care

16 Mar, 2018 | 03:35h | UTC

Big Data and Machine Learning in Health Care – JAMA (free for a limited period)

 


Do Antidepressants Work?

16 Mar, 2018 | 03:36h | UTC

Do Antidepressants Work? – The New York Times (10 articles per month are free)

“The most comprehensive study on them has recently been published, showing mostly modest effects”.

See related meta-analysis and commentaries in our February 23rd issue (see #3)

 


Research: Mapping child growth failure in Africa between 2000 and 2015

16 Mar, 2018 | 03:34h | UTC

Mapping child growth failure in Africa between 2000 and 2015 – Nature (free)

Invited commentary, by Kofi Annan: Data can help to end malnutrition across Africa (free)

Other commentaries: Africa ‘very, very far away’ from meeting global target to end child malnutrition – The Guardian (free) Local Burden of Disease – Child Growth Failure – IHME (free) AND Zooming in on advances and opportunities – IHME (free)

 


Did a pricey cholesterol-lowering drug really reduce deaths, as headlines claim?

16 Mar, 2018 | 03:33h | UTC

Did a pricey cholesterol-lowering drug really reduce deaths, as headlines claim? – Health News Review (free)

See original article and commentaries in our March 12th issue (see #2)

 


Editorial: AI diagnostics need attention

16 Mar, 2018 | 03:31h | UTC

Editorial: AI diagnostics need attention – Nature (free) (via @RasoiniR see Tweet)

 


NICE Guideline: Attention deficit hyperactivity disorder

16 Mar, 2018 | 03:34h | UTC

Guideline: Attention deficit hyperactivity disorder: diagnosis and management – National Institute for Health and Care Excellence (NICE) (free)

 


The ODYSSEY Trial Ends Well— But Will It Be Enough?

16 Mar, 2018 | 03:32h | UTC

#ACC18 – The ODYSSEY Trial Ends Well— But Will It Be Enough? – Cardiobrief (free) AND Ten Quick Thoughts on ODYSSEY – John Mandrola, via Medscape (free registration required)

“An absolute risk reduction of 1.6% in the primary endpoint translates to a number needed to treat of 64. Using the current price of $14,500 per year, Kaul calculated that preventing one event over the trial period of almost 3 years would cost about $2.6 million” (via John Mandrola). This study was presented at #ACC18 and has not been published yet. Among the many commentaries, these two were selected for a balanced point of view.

 


Grader Variability and the Importance of Reference Standards for Evaluating Machine Learning Models for Diabetic Retinopathy

16 Mar, 2018 | 03:30h | UTC

Grader Variability and the Importance of Reference Standards for Evaluating Machine Learning Models for Diabetic Retinopathy – Ophthalmology (link to abstract – $ for full-text)

Commentary: Google’s AI program: Building better algorithms for detecting eye disease – ScienceDaily (free)

 


Research: Aromatherapy Versus Oral Ondansetron for Antiemetic Therapy

16 Mar, 2018 | 03:29h | UTC

Aromatherapy Versus Oral Ondansetron for Antiemetic Therapy Among Adult Emergency Department Patients: A Randomized Controlled Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)

Commentaries: Practice Changing: Inhaled Isopropyl Alcohol Superior to Oral Ondansetron as an Antiemetic – NEJM Journal Watch (free) AND Wake Up And Smell the Isopropyl – Emergency Medicine Literature of Note (free)

 


Panic, chronic anxiety and burnout: doctors at breaking point

16 Mar, 2018 | 03:30h | UTC

Panic, chronic anxiety and burnout: doctors at breaking point – The Guardian (free)

 


Research: Vitamin D and risk of total and site specific cancers

16 Mar, 2018 | 03:26h | UTC

Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort – The BMJ (free)

“Wake me up when there is a positive randomized trial of vitamin D pills for anything” (from Richard Lehman’s review).

 


Richard Lehman’s journal reviews – 12 March 2018

16 Mar, 2018 | 03:28h | UTC

Richard Lehman’s journal reviews, 12 March 2018 – The BMJ Opinion (free)

Richard Lehman reviews the latest research in the top medical journals.

 


Research: Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention

16 Mar, 2018 | 03:22h | UTC

#ACC18 – Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Lipid Lowering in Acute Coronary Syndrome: Is Treatment Early Enough? (free for a limited period)

Commentaries: Statins Evaluation in Coronary Procedures and Revascularization – SECURE-PCI – American College of Cardiology (free) AND No Benefits Likely with Very Early Statins in ACS Patients – MedPage Today (free registration required) AND SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients – TCTMD (free)

 


Research: Risk of stroke in patients with dengue fever

16 Mar, 2018 | 03:24h | UTC

Risk of stroke in patients with dengue fever: a population-based cohort study – Canadian Medical Association Journal (free)

Commentary: Dengue fever linked to increased risk of stroke – CMAJ, via ScienceDaily (free)

 


Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings

16 Mar, 2018 | 03:23h | UTC

Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings – Journal of the American Heart Association (free)

Commentaries: Survival benefit seen for some patients when cardiologists are away at academic conferences – Harvard Medical School, via ScienceDaily (free) AND TCT paradox: Patients more likely to survive MI during interventional cardiology conference – Cardiovascular Business (free)

Related study: Mortality and Treatment Patterns Among Patients Hospitalized With Acute Cardiovascular Conditions During Dates of National Cardiology Meetings – JAMA Internal Medicine (free)

“The study’s release date is particularly timely considering another major conference—the American College of Cardiology’s Scientific Session—kicks off this weekend”. (from Cardiovascular Business)

 


Research: Inflammatory Bowel Disease Linked to Increased Risk in Heart Attack

16 Mar, 2018 | 03:18h | UTC

#ACC18 – Inflammatory Bowel Disease Increases Likelihood of a Heart Attack – American College of Cardiology (free) AND Inflammatory bowel disease may raise heart attack risk – Medical News Today (free) AND Those with IBD twice as likely to have heart attack – Cardiovascular Business (free) AND Inflammatory Bowel Disease Makes Heart Attack Twice as Likely – Cardiosmart (free)

 


Meta-analysis: Getting flu shot may reduce deaths in heart failure

16 Mar, 2018 | 03:16h | UTC

#ACC18 – Getting flu shot halves death risk for heart failure patients – Cardiovascular Business (free) AND Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis – TCTMD (free) AND Flu Shot Cuts Risk for Death by Half in Heart Failure – Medscape (free registration required) AND Getting Flu Vaccine Cuts Risk of Death by Half in People with Heart Failure – American College of Cardiology (free)

This meta-analysis of observational studies suggests a possible benefit.

 


Research: Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery

16 Mar, 2018 | 03:20h | UTC

#ACC18 – Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery – Circulation (free PDF for a limited period)

Commentaries: Hospital Readmissions After Perioperative AMI – American College of Cardiology, Latest in Cardiology (free) AND Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery – TCTMD (free)

 


Research: Aspirin Lowers Risk of Death for Patients with Diabetes, Heart Failure

16 Mar, 2018 | 03:15h | UTC

#ACC18 – Aspirin Lowers Risk of Death for Patients with Diabetes, Heart Failure – American College of Cardiology (free) AND Aspirin Linked to Lower Mortality in Diabetes With Heart Failure – Medscape (free registration required) AND ACC 2018: Aspirin Lowers Risk of Death in Patients With Diabetes and Heart Failure – PracticeUpdate (free registration required)

 


Fri, March 16 – 10 Stories of The Day!

16 Mar, 2018 | 02:54h | UTC

 

1 – Mapping child growth failure in Africa between 2000 and 2015 – Nature (free)

Invited commentary, by Kofi Annan: Data can help to end malnutrition across Africa (free)

Other commentaries: Africa ‘very, very far away’ from meeting global target to end child malnutrition – The Guardian (free) Local Burden of Disease – Child Growth Failure – IHME (free) AND Zooming in on advances and opportunities – IHME (free)

 

2 – Guideline: Attention deficit hyperactivity disorder: diagnosis and management – National Institute for Health and Care Excellence (NICE) (free)

 

3 – State of The Art Review: Pulmonary arterial hypertension: pathogenesis and clinical management – The BMJ (free for a limited period)

Related Guidelines: Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults – CHEST Guideline and Expert Panel Report (free) AND 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (free)

 

4 – Very interesting resource: A Visual introduction to the basic concepts of probability theory – Seeing Theory (free) (via @CochraneUK see Tweet)

 

5 – Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women – Neurology (free)

Commentaries: High Cardiovascular Fitness in Midlife Tied to Lower Dementia Risk Later – NEJM Physician’s First Watch (free) AND Physically fit women nearly 90 percent less likely to develop dementia – American Academy of Neurology, via ScienceDaily (free)

 

6 – Like It Or Not, Personal Health Technology Is Getting Smarter – NPR (free)

“Nice article about wearables related issues, such as medicalization of the healthy, privacy loss, low adherence, uncertain reliability of measurements and uncertain health benefits”. (via @RasoiniR see Tweet)

 

7 – Wearable technology to screen for atrial fibrillation: does it raise more questions than it answers? – HealthNewsReview (free)

Related: Get Ready For A Tsunami Of ECGs – Cardiobrief (free) AND: Thoughts on the Apple Watch and Mobile ECG, by Dr John Mandrola (free) AND Overdiagnosis Only a Matter of Time With ECG Watches – Medscape (free registration required)

 

8 – Panic, chronic anxiety and burnout: doctors at breaking point – The Guardian (free)

 

9 – Statement: American Diabetes Association® Deeply Concerned About New Guidance from American College of Physicians Regarding Blood Glucose Targets for People with Type 2 Diabetes (free)

See original guideline and commentary: ACP Guideline: Hemoglobin A1c Targets for Glycemic Control in Type 2 Diabetes

 

10 – Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial – Gut (link to abstract – $ for full-text)

Commentaries: Calcium and vitamin D supplements may raise risk of polyps – MedicalNewsToday (free) AND Calcium Supplements Up Risk for Precancerous Serrated Polyps – Medscape (free registration required)

See related meta-analysis of RCT showing calcium and vitamin D don’t prevent bone fractures

 


Research: Low-level lead exposure and mortality in US adults

16 Mar, 2018 | 02:43h | UTC

Low-level lead exposure and mortality in US adults: a population-based cohort study – The Lancet Public Health (free)

Commentaries: Lead and the heart: an ancient metal’s contribution to modern disease – The Lancet Public Health (free) AND Lead exposure may be linked to 412,000 premature US deaths yearly, study says – The Guardian (free) AND Lead and CDV deaths in US adults – Science Media Centre (free) AND Expert reaction to lead and CVD deaths in the US – Science Media Centre (free)

 


Guidelines for Aneurysmal Subarachnoid Hemorrhage

16 Mar, 2018 | 02:41h | UTC

Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage – Journal of Korean Neurosurgical Society (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.